Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Biologic and therapeutic role of HER2 in cancer
2003
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
2000
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
ErbB-targeted therapeutic approaches in human cancer
2003
Inflammation and cancer
2002 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer
2003
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Integrin adhesion receptors in tumor metastasis
2003
Cancer Metastasis: Building a Framework
2006 Standout
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Systems Biology of Vascular Endothelial Growth Factors
2008
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Stem cells find their niche
2001 StandoutNature
The Hallmarks of Cancer
2000 Standout
Tumor targeting with a selective gelatinase inhibitor
1999
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck
2004
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Role of concomitant resistance in the development of murine lung metastases
1988
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
1990
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
2012
Cancer-associated carbohydrates identified by monoclonal antibodies
1990
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
Metabolic Labeling of Sialic Acids in Living Animals with Alkynyl Sugars
2009 StandoutNobel
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
1992 Standout
Malignant Gliomas in Adults
2008 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay
1998
Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer
2010
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
The ras gene family and human carcinogenesis
1988
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
1997
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
2011 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Changing views of the role of matrix metalloproteinases in metastasis
1997
Angiogenesis as a therapeutic target
2005 StandoutNature
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
2001
Breast cancer metastasis: markers and models
2005 Standout
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Gene expression profiles of primary breast tumors maintained in distant metastases
2003
Update on brain tumor imaging: from anatomy to physiology.
2006
Metastasizing potentials of mouse mammary tumors and their metastases
1988
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2002
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
2001
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
1995
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Phase I and Pharmacologic Study of the Specific Matrix Metalloproteinase Inhibitor BAY 12-9566 on a Protracted Oral Daily Dosing Schedule in Patients With Solid Malignancies
2000
Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
1987
The pathogenesis of cancer metastasis
1980 StandoutNature
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Spontaneous metastasis: random or selective?
1983
The Biology of Cancer Invasion and Metastasis
1978
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
1998
Biological Diversity in Metastatic Neoplasms: Origins and Implications
1982 Science
Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.
1987
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
2003
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
2005
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
1987 Science
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
2000
Works of S. A. Eccles being referenced
Cross-platform Q-TOF validation of global exo-metabolomic analysis: Application to human glioblastoma cells treated with the standard PI 3-Kinase inhibitor LY294002☆
2008
Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer
1996
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer
1993
Cell Biology of Lymphatic Metastasis The Potential Role of c-erbB Oncogene Signalling
2000
C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors
2002
Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction
1993
Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours
1980
An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chain
1987
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
2001
Studies of mammary carcinoma metastasis in a mouse model system. II: Lectin binding properties of cells in relation to the incidence and organ distribution of metastases
1984
Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c‐Ha‐ras‐1 gene
1986
Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
1994
Sequestration of Macrophages in Growing Tumours and its Effect on the Immunological Capacity of the Host
1974
Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
2000
Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
2001
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
2000
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
1996